Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas which require multiagent therapy for remission induction and are associated with relapse in more than 40% of patients. Spontaneous remission of diffuse large B-cell lymphoma (DLBCL) is a rare occurrence.
Keywords: chemotherapy; diffuse large B‐cell lymphoma; non‐Hodgkin lymphoma; spontaneous remission.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.